Objectives: This study was designed to investigate whether the addition of N-terminal pro-B-type natriuretic peptide-guided, intensive patient management (BM) to multidisciplinary care (MC) improves outcome in patients following hospitalization due to heart failure (HF).
Background: Patients hospitalized due to HF experience frequent rehospitalizations and high mortality.
Methods: Patients hospitalized due to HF were randomized to BM, MC, or usual care (UC).